Prudential Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.69M | Sell |
157,515
-85,360
| -35% | -$2.54M | 0.01% | 931 |
|
|
2025
Q1 | $8.28M | Sell |
242,875
-34,495
| -12% | -$1.18M | 0.01% | 664 |
|
|
2024
Q4 | $14.2M | Buy |
277,370
+104,584
| +61% | +$5.35M | 0.02% | 488 |
|
|
2024
Q3 | $8.83M | Sell |
172,786
-12,969
| -7% | -$663K | 0.01% | 733 |
|
|
2024
Q2 | $8.32M | Buy |
185,755
+41,121
| +28% | +$1.84M | 0.01% | 722 |
|
|
2024
Q1 | $6.77M | Buy |
144,634
+7,689
| +6% | +$360K | 0.01% | 811 |
|
|
2023
Q4 | $4.87M | Buy |
136,945
+4,316
| +3% | +$154K | 0.01% | 945 |
|
|
2023
Q3 | $3.89M | Buy |
132,629
+60,864
| +85% | +$1.79M | 0.01% | 1004 |
|
|
2023
Q2 | $1.29M | Buy |
+71,765
| New | +$1.29M | ﹤0.01% | 1675 |
|